Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir
US5962725A · kind A · utility
7Cited by
13References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 5, 1997 |
| Grant date | Oct 5, 1999 |
| Priority date | — |
| Expiry date | Sep 5, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
HIV protease inhibitors inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds can be prepared by the novel methods of the present invention using the novel inventive compounds and intermediates.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.